Denver Health and Hospital Authority

Research site

About

Built for Speed and Real-World Relevance

Location

1391 N Speer Boulevard, Denver, Colorado, United States of America

Website

https://www.denverhealth.org/services/academic-affairs/office-of-research/clinical-trials-partnership

Site insights

Top conditions

Top treatments

Acetaminophen

Eslicarbazepine Acetate

Reparixin

Acetylcysteine

Ranolazine

Bevacizumab

BE1116

Crizanlizumab

Ticagrelor

Steroids

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Contact this site

Amanda Breeden

Verified by this site

Active trials

4 of 120 total trials

OPT101 in Patients With Community Acquired Pneumonia (CAP) With Sepsis

OPT101-100-40 is a multicenter, randomized, placebo-controlled, multiple-ascending-dose, sequential-group, investigator- and participant-blinded, spo...

Not yet enrolling

Community Acquired Pneumonia (CAP)

Sepsis

Other: Placebo

Drug: OPT101

Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease (FourLight-3)

The purpose of this study is to determine the safety and efficacy of PF-07220060 with letrozole compared to approved treatments (ie, palbociclib, rib...

Active, not recruiting

Breast Cancer

Drug: PF-07220060

Drug: letrozole

The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disease

The objective of this prospective, multicenter, randomized, controlled clinical trial is to demonstrate the superiority of the VBX Device for primary...

Enrolling

Aortoiliac Occlusive Disease

Peripheral Arterial Disease

Device: Stenting of the Common and/or External Iliac Arteries with the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis

Device: Stenting of the Common and/or External Iliac Arteries with Bare Metal Stent

To Compare the Efficacy and Safety of the ATEV With AVF in Female Patients With End-Stage Renal Disease Requiring Hemodialysis

The goal of this clinical trial is to compare the number of catheter-free days (CFD) and the rate and severity of any dialysis access-related infecti...

Enrolling

End Stage Renal Disease (ESRD)

Other: AVF

Biological: Acellular Tissue Engineered Vessel (ATEV)